These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16774946)

  • 1. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch repair and treatment resistance in ovarian cancer.
    Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
    BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
    Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
    Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variants in mismatch repair genes and risk of colorectal cancer.
    Koessler T; Oestergaard MZ; Song H; Tyrer J; Perkins B; Dunning AM; Easton DF; Pharoah PD
    Gut; 2008 Aug; 57(8):1097-101. PubMed ID: 18364438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
    Mann A; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Ponder BA; Kjaer SK; Gayther SA; Thompson DJ; Pharoah PD; Song H
    Eur J Cancer; 2008 Oct; 44(15):2259-65. PubMed ID: 18723338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
    de Vos M; Hayward B; Bonthron DT; Sheridan E
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
    Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
    Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
    Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
    Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM
    Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
    Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
    Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
    Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
    BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 116G > A MSH6 and IVS1-1121C > T PMS2 Genes Polymorphisms Modulate the Risk of the Sporadic Colorectal Cancer Development in Polish Population.
    Zelga P; Przybyłowska-Sygut K; Zelga M; Dziki A; Majsterek I
    Pathol Oncol Res; 2018 Apr; 24(2):231-235. PubMed ID: 28451866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.